← Back to Search

Antibacterial

nano-silver gel for Normal Subjects

Phase 3
Waitlist Available
Led By Mary S McCarthy, RN, PhD, CNSN
Research Sponsored by Madigan Army Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 minutes
Awards & highlights

Study Summary

The purpose of this pilot study is to compare the antimicrobial efficacy of silver nanoparticle gel to a commercialized alcohol-based hand gel on bacterial counts isolated from the hands of 40 volunteers seeded with Serratia marcescens, a surrogate microbial marker. Specific aims of this study are: Aim #1: Compare the immediate antimicrobial efficacy of a one-time application of silver nanoparticle gel (SilvaSorb , AcryMed, Inc., Portland, OR) versus an alcohol-based hand gel (Purell, GoJo Industries, Akron, OH) in reducing transient bacterial counts isolated from hands seeded with S. marcescens. Aim # 2: Compare the persistent antimicrobial efficacy of a one-time application of silver nanoparticle gel (SilvaSorb) versus an alcohol-based hand gel (Purell) over a 10 minute time frame in producing a persistent reduction on transient bacterial counts isolated from hands seeded with S. marcescens. Aim # 3: Compare user acceptability of silver nanoparticle gel (SilvaSorb) versus an alcohol-based hand gel (Purell) using a self-assessment questionnaire.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Antimicrobial efficacy (as measured by the percent change in microbial counts from baseline of subjects)
Secondary outcome measures
User acceptability (as measured by the total of points received per product from a questionnaire)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: nano-silver gelExperimental Treatment1 Intervention
Group II: alcohol-based gelActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Madigan Army Medical CenterLead Sponsor
48 Previous Clinical Trials
18,164 Total Patients Enrolled
Mary S McCarthy, RN, PhD, CNSNPrincipal InvestigatorNurse Researcher, Madigan Army Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Efficacy of Silver Nanoparticle Gel Versus a Common Antibacterial Hand Gel
2008. "Efficacy of Silver Nanoparticle Gel Versus a Common Antibacterial Hand Gel". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00659204.
All > Cte
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top